Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells (Q45883837)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

0 references

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

Ignacio Melero, MD-PhD

4

object named as

Ignacio Melero

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

author name string

Maria Vera

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

Nerea Razquin

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

Gloria González-Aseguinolaza

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

publication date

1 November 2005

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

Molecular Therapy

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

12

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

950-959

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Cytokine gene transfer into dendritic cells for cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Interleukin-12 in anti-tumor immunity and immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Cancer immunotherapy: a treatment for the masses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

A new packaging cell line for SV40 vectors that eliminates the generation of T-antigen-positive, replication-competent recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Simian virus-40 as a gene therapy vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Factors influencing the production of recombinant SV40 vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

In vitro-packaged SV40 pseudovirions as highly efficient vectors for gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Gene delivery to the liver using simian virus 40-derived vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

The roles of IFN gamma in protection against tumor development and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

In vivo cytotoxic T-lymphocyte induction may take place via CD8 T helper lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.030

7 January 2021

Identifiers

10.1016/J.YMTHE.2005.03.030

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15921960

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45883837&oldid=2088359783"